CytoMed makes cash bid for potential acquisition of TC BioPharm Limiteds relevant assets
SINGAPORE, Oct. 14, 2025 (GLOBE NEWSWIRE) -- CytoMed Therapeutics Limited (NASDAQ: GDTC)…
EnKash Unveils India’s First Unified Corporate Card Ecosystem for Businesses
MUMBAI, India, Oct. 14, 2025 /PRNewswire/ -- EnKash, India's leading full-stack business…
NEXEN TIRE Supplies OE Tires for KIAs SUV, the Kia EV5
- ROADIAN GTX and N’FERA SPORT to be mounted on KIA’s core…
Herbalife India Bags ‘Exceptional Employee Experience’ Title for Large-scale Enterprises
BENGALURU, India, Oct. 13, 2025 /PRNewswire/ -- Herbalife India, a premier health…
Innovative and Leading, Gotion High-Tech Empowers Saudi Arabia to Build a Model for Green Zero-Carbon Energy
RIYADH, Saudi Arabia, Oct. 13, 2025 /PRNewswire/ -- At the Solar &…
Merus Announces Petosemtamab in Metastatic Colorectal Cancer Abstract Selected for Plenary Session Oral Presentation at the AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics
- Plenary session oral presentation: Friday, October 24 10:00 -11:40 a.m. ET…
Quanta Therapeutics Announces First Clinical Data Presentation for QTX3034, an Oral G12D-Preferring Multi-KRAS Inhibitor, at 2025 AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics
RADNOR, Pa. and SOUTH SAN FRANCISCO, Calif., Oct. 13, 2025 (GLOBE NEWSWIRE)…
Collaboration across Bybit, DigiFT and UBS uMINT expands Collateral Solution for Institutions
DUBAI, UAE, Oct. 13, 2025 /PRNewswire/ -- Bybit, the world's second-largest cryptocurrency exchange…
FDA Approves Expanded Indication for UZEDY (risperidone) Extended-Release Injectable Suspension as a Treatment for Adults Living with Bipolar I Disorder
FDA approves UZEDY® (risperidone) extended-release injectable suspension for subcutaneous use as monotherapy…
Wild Alaskan Company Cuts Snowflake Costs by 48% with Yuki, as Yuki Launches ModelLevel Warehouse Optimization for dbt at Coalesce 2025
LAS VEGAS, Oct. 12, 2025 (GLOBE NEWSWIRE) -- As Wild Alaskan scaled…
